Sinovac Biotech Ltd (SVA) — Financial Flexibility Index
Sinovac Biotech Ltd (SVA) has a Financial Flexibility Index of 0.12x as of December 2023. Free cash flow of $198.75 Million (operating CF $146.01 Million minus capex $52.75 Million) represents 0% of total liabilities ($1.64 Billion). Check SVA strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Sinovac Biotech Ltd Financial Flexibility Index (2000–2023)
Historical Financial Flexibility Index trend for Sinovac Biotech Ltd across 24 annual periods. See SVA current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Sinovac Biotech Ltd (2000–2023)
Year-by-year free cash flow to debt coverage for Sinovac Biotech Ltd. For the full company profile including market capitalisation, see market cap of Sinovac Biotech Ltd.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2023 | 0.15x | $251.71 Million | $106.02 Million | $1.64 Billion | ▲ +158.7% |
| 2022 | -0.26x | $-367.38 Million | $-770.75 Million | $1.40 Billion | ▼ -104.7% |
| 2021 | 5.60x | $16.07 Billion | $15.35 Billion | $2.87 Billion | ▲ +620.2% |
| 2020 | 0.78x | $606.96 Million | $479.31 Million | $781.20 Million | ▲ +56.5% |
| 2019 | 0.50x | $49.70 Million | $39.07 Million | $100.10 Million | ▲ +185.1% |
| 2018 | 0.17x | $13.56 Million | $7.94 Million | $77.85 Million | ▼ -80.2% |
| 2017 | 0.88x | $71.67 Million | $59.76 Million | $81.69 Million | ▲ +2655.1% |
| 2016 | -0.03x | $-2.81 Million | $-15.46 Million | $81.69 Million | ▼ -124.0% |
| 2015 | 0.14x | $9.51 Million | $4.21 Million | $66.42 Million | ▲ +1663.4% |
| 2014 | 0.01x | $786.00K | $-10.13 Million | $96.80 Million | ▼ -92.6% |
| 2013 | 0.11x | $10.71 Million | $5.58 Million | $97.05 Million | ▲ +9031.7% |
| 2012 | 0.00x | $-98.00K | $-16.25 Million | $79.33 Million | ▼ -100.3% |
| 2011 | 0.42x | $29.39 Million | $13.94 Million | $70.61 Million | ▲ +149.8% |
| 2010 | 0.17x | $11.10 Million | $-14.28 Million | $66.60 Million | ▼ -80.7% |
| 2009 | 0.86x | $52.73 Million | $48.41 Million | $61.01 Million | ▲ +42.1% |
| 2008 | 0.61x | $14.48 Million | $10.50 Million | $23.80 Million | ▲ +120.2% |
| 2007 | 0.28x | $6.78 Million | $4.32 Million | $24.55 Million | ▲ +976.0% |
| 2006 | -0.03x | $-495.31K | $-1.64 Million | $15.70 Million | ▼ -141.6% |
| 2005 | 0.08x | $520.01K | $-1.13 Million | $6.86 Million | ▲ +361.3% |
| 2004 | 0.02x | $112.72K | $-1.54 Million | $6.86 Million | ▲ +106.6% |
| 2003 | -0.25x | $-993.86K | $-1.72 Million | $4.01 Million | ▲ +40.8% |
| 2002 | -0.42x | $-57.25K | $-58.05K | $136.81K | ▲ +18.9% |
| 2001 | -0.52x | $-491.09K | $-494.80K | $952.15K | ▲ +0.0% |
| 2000 | -0.52x | $-491.09K | $-494.80K | $952.15K | — |